Alnylam Switzerland GmbH
Company Overview
Management
Alnylam UK Limited
London, GB
Llc member
Jeffrey Poulton
Acton, US
Member of the management board
Individual signing authority
Katarzyna
Zug
Member of the management board
Individual signing authority
Carlos Dal Secco Pagnano
Risch
Chairperson of the management board
Individual signing authority
Mario Kumschick
Zürich
Having right to sign
Individual signing authority
Emmanuel Dulac
Baar
Having right to sign
Individual signing authority
David Jones
Chavannes-de-Bogis
Member of the executive board
Individual signing authority
David Jones
Vevey
Chairperson of the management board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 3669 | 23.02.2026 | 1006580576 | 26.02.2026 | 1006580576 |
| 2 | 2374 | 04.02.2026 | 1006563662 | 09.02.2026 | 1006563662 |
| 3 | 11350 | 14.07.2023 | 1005798921 | 19.07.2023 | 1005798921 |
| 4 | 13373 | 02.09.2022 | 1005556490 | 07.09.2022 | 1005556490 |
| 5 | 12066 | 15.06.2021 | 1005221722 | 18.06.2021 | 1005221722 |
| 6 | 4752 | 02.04.2020 | 1004867449 | 07.04.2020 | 1004867449 |
| 7 | 13211 | 13.09.2019 | 1004718575 | 18.09.2019 | 1004718575 |
| 8 | 10264 | 17.07.2019 | 1004681007 | 22.07.2019 | 1004681007 |
| 9 | 9499 | 29.06.2018 | 4334959 | 04.07.2018 | 4334959 |
| 10 | 13534 | 24.10.2017 | 3835369 | 27.10.2017 | 3835369 |
Company Purpose
Klinische Forschung, Entwicklung und Vermarktung von Arzneimitteln; vollständige Zweckumschreibung gemäss Statuten